These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 18537151

  • 1. Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters.
    Kanda M, Nomoto S, Nishikawa Y, Sugimoto H, Kanazumi N, Takeda S, Nakao A.
    J Surg Oncol; 2008 Sep 01; 98(3):190-6. PubMed ID: 18537151
    [Abstract] [Full Text] [Related]

  • 2. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
    Yao DF, Wu XH, Zhu Y, Shi GS, Dong ZZ, Yao DB, Wu W, Qiu LW, Meng XY.
    Hepatobiliary Pancreat Dis Int; 2005 May 01; 4(2):220-6. PubMed ID: 15908319
    [Abstract] [Full Text] [Related]

  • 3. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
    Moon JI, Kim JM, Jung GO, Chun JM, Choi GS, Park JB, Kwon CH, Kim SJ, Jo JW.
    Korean J Hepatol; 2008 Jun 01; 14(2):185-96. PubMed ID: 18617766
    [Abstract] [Full Text] [Related]

  • 4. Correlation of four vascular specific growth factors with carcinogenesis and portal vein tumor thrombus formation in human hepatocellular carcinoma.
    Li Q, Xu B, Fu L, Hao XS.
    J Exp Clin Cancer Res; 2006 Sep 01; 25(3):403-9. PubMed ID: 17167981
    [Abstract] [Full Text] [Related]

  • 5. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
    Yang LY, Tao YM, Ou DP, Wang W, Chang ZG, Wu F.
    Clin Cancer Res; 2006 Oct 01; 12(19):5673-9. PubMed ID: 17020969
    [Abstract] [Full Text] [Related]

  • 6. Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma.
    Li XM, Tang ZY, Qin LX, Zhou J, Sun HC.
    J Exp Clin Cancer Res; 1999 Dec 01; 18(4):511-7. PubMed ID: 10746978
    [Abstract] [Full Text] [Related]

  • 7. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
    El-Assal ON, Yamanoi A, Soda Y, Yamaguchi M, Igarashi M, Yamamoto A, Nabika T, Nagasue N.
    Hepatology; 1998 Jun 01; 27(6):1554-62. PubMed ID: 9620326
    [Abstract] [Full Text] [Related]

  • 8. Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma.
    Kuboki S, Shimizu H, Mitsuhashi N, Kusashio K, Kimura F, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Miyazaki M.
    J Gastroenterol Hepatol; 2008 Jul 01; 23(7 Pt 2):e157-64. PubMed ID: 17931370
    [Abstract] [Full Text] [Related]

  • 9. Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma.
    Li XM, Tang ZY, Zhou G, Lui YK, Ye SL.
    J Exp Clin Cancer Res; 1998 Mar 01; 17(1):13-7. PubMed ID: 9646228
    [Abstract] [Full Text] [Related]

  • 10. [Expression of liver-type fatty acid-binding protein and vascular endothelial growth factor and their correlation in human hepatocellular carcinoma].
    Dong LH, Li H, Wang F, Li FQ, Zhou HY, Yang HJ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar 01; 27(3):318-21. PubMed ID: 17425983
    [Abstract] [Full Text] [Related]

  • 11. [Expression of vascular endothelial growth factor correlates with invasion and metastasis of hepatocellular carcinoma].
    Li X, Tang Z, Zhou G.
    Zhonghua Zhong Liu Za Zhi; 1998 Jan 01; 20(1):12-4. PubMed ID: 10921046
    [Abstract] [Full Text] [Related]

  • 12. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma.
    Wang XQ, Luk JM, Leung PP, Wong BW, Stanbridge EJ, Fan ST.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):483-9. PubMed ID: 15701831
    [Abstract] [Full Text] [Related]

  • 13. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS, Zheng SS, Wu LJ, Ding W, Ma ZM, Wang ZM, Teng LS, Zhao WH.
    Zhonghua Wai Ke Za Zhi; 2006 May 01; 44(9):603-8. PubMed ID: 16784653
    [Abstract] [Full Text] [Related]

  • 14. The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma.
    Ikeguchi M, Iwamoto A, Taniguchi K, Katano K, Hirooka Y.
    J Exp Clin Cancer Res; 2005 Sep 01; 24(3):415-21. PubMed ID: 16270528
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K, Tanaka F, Kosaka Y, Mimori K, Uetake H, Inoue H, Sugihara K, Mori M.
    Ann Surg Oncol; 2008 May 01; 15(5):1530-7. PubMed ID: 18259822
    [Abstract] [Full Text] [Related]

  • 16. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma.
    Suzuki K, Hayashi N, Miyamoto Y, Yamamoto M, Ohkawa K, Ito Y, Sasaki Y, Yamaguchi Y, Nakase H, Noda K, Enomoto N, Arai K, Yamada Y, Yoshihara H, Tujimura T, Kawano K, Yoshikawa K, Kamada T.
    Cancer Res; 1996 Jul 01; 56(13):3004-9. PubMed ID: 8674055
    [Abstract] [Full Text] [Related]

  • 17. Expression of vascular endothelial growth factor in human hepatocellular carcinoma.
    Yamaguchi R, Yano H, Iemura A, Ogasawara S, Haramaki M, Kojiro M.
    Hepatology; 1998 Jul 01; 28(1):68-77. PubMed ID: 9657098
    [Abstract] [Full Text] [Related]

  • 18. Clinical significance of thrombospondin 1 expression in hepatocellular carcinoma.
    Poon RT, Chung KK, Cheung ST, Lau CP, Tong SW, Leung KL, Yu WC, Tuszynski GP, Fan ST.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):4150-7. PubMed ID: 15217952
    [Abstract] [Full Text] [Related]

  • 19. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.
    Yang XR, Xu Y, Yu B, Zhou J, Qiu SJ, Shi GM, Zhang BH, Wu WZ, Shi YH, Wu B, Yang GH, Ji Y, Fan J.
    Gut; 2010 Jul 15; 59(7):953-62. PubMed ID: 20442200
    [Abstract] [Full Text] [Related]

  • 20. Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma.
    Uematsu S, Higashi T, Nouso K, Kariyama K, Nakamura S, Suzuki M, Nakatsukasa H, Kobayashi Y, Hanafusa T, Tsuji T, Shiratori Y.
    J Gastroenterol Hepatol; 2005 Apr 15; 20(4):583-8. PubMed ID: 15836707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.